Not yet recruiting
Arteriosclerosis
Not yet recruitingA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
Investigational
A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
Investigational
- Disease:Arteriosclerosis
- Substances:Muvalaplin
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Muvalaplin
